Haptoglobin polymorphisms are associated with Crohn's disease, disease behavior, and extraintestinal manifestations in hungarian patients

Digestive Diseases and Sciences

Volumn 52, Issue 5, 2007, Pages 1279-1284

  Papp, Maria ^a   Lakatos, Peter Laszlo ^b   Palatka, Karoly ^a   Foldi, Ildiko ^a   Udvardy, Miklos ^a   Harsfalvi, Jolan ^a   Tornai, Istvan ^a   Vitalis, Zsuzsanna ^a   Dinya, Tamas ^a   Kovacs, Agota ^c   Molnar, Tamas ^d   Demeter, Pal ^e   Papp, Janos ^b   Lakatos, Laszlo ^f   Altorjay, Istvan ^a   Fuszek, Peter ^b   Horvath, Henrik Csaba ^b   Vargha, Peter ^b   Fischer, Simon ^b   Osztovits, Janos ^b   Bene, Laszlo ^c   Nagy, Ferenc ^d   Lonovics, Janos ^d   Balint, Levente ^e   Huoranszky, Ferenc ^e   Dobo, Istvan ^e   Tulassay, Zsolt ^g   Herszenyi, Laszlo ^g   Miheller, Pal ^g   Nemeth, Annamaria ^g   Szekely, Gyorgy ^h   Erdelyi, Zsuzsanna ^f   Mester, Gabor ^f   Molnar, Csaba ^f   Pandur, Tunde ^f   more..

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Erzsebet Hospital   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e St Margit Hospital   (Hungary)

^f Csolnoky Ferenc County Hospital   (Hungary)

^g SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^h ST JOHN'S HOSPITAL   (Hungary)

Author keywords

Crohn's disease; Disease behavior; Haptoglobin polymorphism; Primary sclerosing cholangitis; Th1 Th2 orientation

Indexed keywords

AZATHIOPRINE; HAPTOGLOBIN; STEROID;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DRUG DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HEALTH BEHAVIOR; HUMAN; HUNGARY; IMMUNOCHEMISTRY; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPTOGLOBINS; HUMANS; HUNGARY; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 34247213983     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9615-1     Document Type: Article

References (29)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-429
2. Ahmad T, Tamboli CP, Jewell D, Colombel JF (2004) Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126:1533-1549
3. Sadrzadeh SM, Bozorgmehr J (2004) Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 121 (Suppl):S97-S104
4. Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42:1589-1600
5. Wassell J (2000) Haptoglobin: function and polymorphism. Clin Lab 46:547-552
6. Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E (2003) Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108:144-151
7. Xie Y, Li Y, Zhang Q, Stiller MJ, Wang CL, Streilein JW (2000) Haptoglobin is a natural regulator of Langerhans cell function in the skin. J Dermatol Sci 24:25-37
8. El-Ghmati SM, Arredouani M, Van Hoeyveld EM, Ceuppens JL, Stevens EA (2002) Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation. Scand J Immunol 55:352-358
9. Levy AP (2003) Genetics of diabetic cardiovascular disease: identification of a major susceptibility gene. Acta Diabetol Suppl 2:S330-S333
10. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198-201
11. Langlois M, Delanghe J, Philippe J, Ouyang J, Bernard D, De Buyzere M, Van Nooten G, Leroux-Roels G (1997) Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD22. Eur J Clin Chem Clin Biochem 35:199-205
12. Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL (2004) Striking elevation in the incidence and prevalence of inflammatory bowel disease in a province of Western Hungary between 1977-2001. World J Gastroenterol 10:404-409
13. Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z, Molnar T, Reinisch W, Papp J, Mozsik G, Ferenci P, Hungarian IBD Study Group (2005) Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol 11:1489-1495
14. Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170:2-6, discussion 16-19
15. Munkholm P, Langholz E, Davidsen M, Binder V (1994) Frequency of glucocorticoid resistance and dependency in Crohn's disease. Gut 35:360-362
16. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8-15
17. Yang SE, Min WK, Park H, Chun S, Nah J, Kim JQ (2000) Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem. Ann Clin Biochem 37:205-209
18. Tauszik T, Szabo L (1992) Haptoglobin polymorphism in Hungary. Gene Geogr 6:153-157
19. Shanahan F (2002) Crohn's disease. Lancet 359:62-69
20. Bottini N, Gloria-Bottini F, Amante A, Saccucci P, Bottini E (2005) Genetic polymorphism and TH1/TH2 orientation. Int Arch Allergy Immunol 138:328-333
21. Talwalkar JA, Lindor KD (2005) Primary sclerosing cholangitis. Inflamm Bowel Dis 11:62-72
22. Aoki CA, Bowlus CL, Gershwin ME (2005) The immunobiology of primary sclerosing cholangitis. Autoimmun Rev 4:137-143
23. Cameron RG, Blendis LM, Neuman MG (2001) Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem 34:195-201
24. Wiencke K, Spurkland A, Schrumpf E, Boberg KM (2001) Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 34:625-630
25. Orchard T (2003) Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep 5:512-517
26. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL (2003) Association of extraintestinal manifestations of inflammatory bowel disease (IBD) in a province of Western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 9:2300-2307
27. Kasvosve I, Gomo ZA, Mvundura E, Moyo VM, Saungweme T, Khumalo H, Gordeuk VR, Boelaert JR, Delanghe JR, De Bacquer D, Gangaidzo IT (2000) Haptoglobin polymorphism and mortality in patients with tuberculosis. Int J Tuberc Lung Dis 4:771-775
28. Ubaidullaev AM, Kazakov KS, Khakimov MA (2002) Genetic variants of haptoglobin in patients with nephrotuberculosis. Probl Tuberk 7:42-43
29. Eisaev BA (1995) Results of the treatment of patients with recurrence of pulmonary tuberculosis with different types of haptoglobin. Probl Tuberk 6:20-22